SALMAR And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – SALMAR (SALM.OL), SPAREBANKEN VEST (SVEG.OL), RANA GRUBER (RANA.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. SALMAR (SALM.OL)

45.8% sales growth and 18.21% return on equity

SalMar ASA, an aquaculture company, produces and sells farmed salmon in Asia, the United States, Canada, Norway, rest of Europe, and internationally. It is involved in the broodfish, lumpfish, and smolt production activities; and marine-phase farming, harvesting, packaging, processing, and selling farmed salmon. The company sells its products to importers/exporters, processing companies, and retail chains through in-house sales force and/or through partners. SalMar ASA was founded in 1991 and is headquartered in Kverva, Norway.

Earnings Per Share

As for profitability, SALMAR has a trailing twelve months EPS of kr17.49.

PE Ratio

SALMAR has a trailing twelve months price to earnings ratio of 24.75. Meaning, the purchaser of the share is investing kr24.75 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.21%.

2. SPAREBANKEN VEST (SVEG.OL)

30.4% sales growth and 13.51% return on equity

Sparebanken Vest, a financial services company, provides banking and financing services in the counties of Vestland and Rogaland, Norway. It operates through Corporate Market, Retail Market, Bulder Bank, Treasury, and Estate Agency Activities segments. The company is also involved in the estate agency and home mortgage activities. As of December 31, 2020, it had 33 points of sale outlets. The company was founded in 1823 and is headquartered in Bergen, Norway.

Earnings Per Share

As for profitability, SPAREBANKEN VEST has a trailing twelve months EPS of kr7.36.

PE Ratio

SPAREBANKEN VEST has a trailing twelve months price to earnings ratio of 13.59. Meaning, the purchaser of the share is investing kr13.59 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.51%.

Yearly Top and Bottom Value

SPAREBANKEN VEST’s stock is valued at kr100.00 at 21:20 EST, under its 52-week high of kr109.40 and way above its 52-week low of kr77.70.

Sales Growth

SPAREBANKEN VEST’s sales growth is 30.1% for the current quarter and 30.4% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 0.4%, now sitting on 5.19B for the twelve trailing months.

Volume

Today’s last reported volume for SPAREBANKEN VEST is 32366 which is 56.42% below its average volume of 74272.

3. RANA GRUBER (RANA.OL)

20.1% sales growth and 70.08% return on equity

Rana Gruber AS engages in the mining, production, and sale of iron ore concentrate primarily to steel producers and the chemical industry. It excavates, processes, and sells iron oxide in the form of hematite, magnetite, and iron oxide pigments. The company also produces and sells micronized iron oxides and other dissemination of iron ore for paint manufactures, as well as building and automotive industries. It offers its products under the Rana Gruber Concentrates and Colorana brands. The company also exports its products worldwide. Rana Gruber AS was founded in 1937 and is headquartered in Mo i Rana, Norway.

Earnings Per Share

As for profitability, RANA GRUBER has a trailing twelve months EPS of kr7.3.

PE Ratio

RANA GRUBER has a trailing twelve months price to earnings ratio of 8.63. Meaning, the purchaser of the share is investing kr8.63 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 70.08%.

4. FRØY (FROY.OL)

14% sales growth and 10.16% return on equity

Frøy ASA provides integrated service to the aquaculture industry in Norway. The company offers wellboat services, sea freight, de-lice and treatment, mooring and laying, ring washing and cage services, net washing and mending, inspection and certification, bottom mapping and documentation, slep, diving and ROV, and control system. It owns and operates 18 wellboats, 60 aqua service vessels, 3 feed transport vessels, and 13 local offices along the Norwegian coast. The company was founded in 2019 and is headquartered in Sistranda, Norway.

Earnings Per Share

As for profitability, FRØY has a trailing twelve months EPS of kr4.68.

PE Ratio

FRØY has a trailing twelve months price to earnings ratio of 13.76. Meaning, the purchaser of the share is investing kr13.76 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.16%.

5. EQUASENS (EQS.PA)

11.3% sales growth and 28.59% return on equity

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 28.59%.

6. ORKLA (ORK.OL)

6.1% sales growth and 12.77% return on equity

Orkla ASA engages in branded consumer goods, and industrial and financial investment businesses. The company offers branded products, including frozen pizza, ketchup, soups, sauces, bread toppings, and ready-to-eat meals through grocery retail trade, as well as the out-of-home, convenience store, and petrol station sectors. It also provides confectionery, biscuit, and snack products; and develops crispbread products, as well as energy snack meals. In addition, the company offers personal care and cleaning products; dietary supplement, sport nutrition, and weight control products; wound care products and first aid equipment; painting tools; basic garments; and professional cleaning products. Further, it operates Gymgrossisten and Bodystore e-commerce portals for health and sports nutrition products; and restaurants. Additionally, the company supplies margarine and butter blends, bread and cake improvers and mixes, yeast, marzipan, and ice cream ingredients; produces and supplies hydro power to the Nordic power market; and develops and sells real estate properties. It offers its food products under the Grandiosa, TORO, Stabburet, Felix, Paulúns, Abba, Kalles, Beauvais, Den Gamle Fabrik, Spilva, Vitana, MTR, and Eastern brands; confectionery and snacks under the KiMs, Nidar, Stratos, Göteborgs Kex, Sætre, OLW, Panda, Laima, Selga, Taffel, Adazu, and Kalev brands; health and sports nutrition under Zalo, Jif, Bliw, Grumme, Blenda, Define, Möller's, Collett, Nutrilett, Maxim, Norgesplaster, and Salvequick brands; and food ingredients under Odense, Mors Hjemmebakte, KronJäst, Bakkedal and NATURLI' brands. It has operations in Norway, Sweden, Denmark, Finland, Iceland, the Baltics, rest of Europe, and internationally. The company is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, ORKLA has a trailing twelve months EPS of kr4.37.

PE Ratio

ORKLA has a trailing twelve months price to earnings ratio of 15.92. Meaning, the purchaser of the share is investing kr15.92 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.77%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ORKLA’s EBITDA is 33.43.

Volume

Today’s last reported volume for ORKLA is 375771 which is 71.84% below its average volume of 1334790.

Moving Average

ORKLA’s worth is under its 50-day moving average of kr72.28 and under its 200-day moving average of kr75.72.

Leave a Reply

Your email address will not be published. Required fields are marked *